#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA867962	F	Activity at human FPRL1-mediated calcium mobilization in CHO cells	Homo sapiens	36		cell-based format	Scientific Literature
2.	ALA4737358	F	Antiinflammatory activity in human neutrophils assessed as reduction in adhesion at 1 to 100 nM preincubated for 30 mins followed addition to assay plate measured after 20 mins by microscopic imaging analysis	Homo sapiens	5		cell-based format	Scientific Literature
3.	ALA5235499	B	Agonist activity at human FPR1 expressed in CHO-A12 cells assessed as cAMP level incubated for 1.5 hr by HTRF assay	Homo sapiens	2		cell-based format	Scientific Literature
4.	ALA5235500	B	Agonist activity at human FPR2 expressed in CHO-A12 cells assessed as cAMP level incubated for 1.5 hr by HTRF assay	Homo sapiens	2		cell-based format	Scientific Literature
5.	ALA5235501	B	Agonist activity at mouse FPR1 expressed in CHO-A12 cells assessed as cAMP level incubated for 1.5 hr by HTRF assay	Mus musculus	2		cell-based format	Scientific Literature
6.	ALA5235502	B	Agonist activity at mouse FPR2 expressed in CHO-A12 cells assessed as cAMP level incubated for 1.5 hr by HTRF assay	Mus musculus	2		cell-based format	Scientific Literature
7.	ALA5235514	B	Agonist activity at mouse FPR3 expressed in CHO-A12 cells assessed as cAMP level incubated for 1.5 hr by HTRF assay	Mus musculus	1		cell-based format	Scientific Literature
8.	ALA5235515	B	Agonist activity at human FPR2 expressed in CHO-K1 cells by beta-arrestin recruitment assay	Homo sapiens	1		cell-based format	Scientific Literature
9.	ALA5235516	F	Induction of cell migration in human HL-60 cells incubated for 120 mins by transwell assay	Homo sapiens	1		cell-based format	Scientific Literature
10.	ALA5235517	F	Inhibition of cell migration in human HL-60 cells incubated for 120 mins in presence of serum amyloid A by transwell assay	Homo sapiens	1		cell-based format	Scientific Literature
11.	ALA5235518	F	Neuroprotective activity against Myocardial infarction C57BL/6 mouse model assessed as reduction in infarct area at 1 mg/kg,po qd measured after 4 weeks	Mus musculus	1		organism-based format	Scientific Literature
12.	ALA5235519	F	Neuroprotective activity against Myocardial infarction C57BL/6 mouse model assessed as reduction in infarct area at 10 mg/kg,po qd measured after 4 weeks	Mus musculus	1		organism-based format	Scientific Literature
13.	ALA5235520	F	Neuroprotective activity against ischemia-reperfusion injury Sprague-Dawley rat model assessed as increase in ejection fraction at 10 mg/kg,po qd measured after 6 weeks	Rattus norvegicus	1		organism-based format	Scientific Literature
14.	ALA5235521	F	Neuroprotective activity against ischemia-reperfusion injury Sprague-Dawley rat model assessed as increase in proximal viable myocardium at 10 mg/kg,po qd measured after 6 weeks	Rattus norvegicus	1		organism-based format	Scientific Literature
15.	ALA5235522	F	Neuroprotective activity against ischemia-reperfusion injury Sprague-Dawley rat model assessed as increase in mid viable myocardium at 10 mg/kg,po qd measured after 6 weeks	Rattus norvegicus	1		organism-based format	Scientific Literature
16.	ALA5235523	F	Neuroprotective activity against ischemia-reperfusion injury Sprague-Dawley rat model assessed as increase in distal viable myocardium at 10 mg/kg,po qd measured after 6 weeks	Rattus norvegicus	1		organism-based format	Scientific Literature
17.	ALA5235524	F	Neuroprotective activity against Myocardial infarction C57BL/6 mouse model assessed as fold increase in infarct wall thickness at 10 mg/kg,po qd measured after 4 weeks	Mus musculus	1		organism-based format	Scientific Literature